Astria Therapeutics Inc.

NASDAQ: ATXS · Real-Time Price · USD
6.85
0.09 (1.33%)
At close: Aug 15, 2025, 3:59 PM
6.85
0.00%
After-hours: Aug 15, 2025, 04:10 PM EDT

Astria Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-116.92M -108.04M -94.26M -100.04M -93.24M -81.63M -72.89M -54.74M -49.01M -47.7M -51.83M -48.06M -43.94M -40.15M -194.91M -194.4M -197.39M -199.43M
Depreciation & Amortization
-1.89M n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Stock-Based Compensation
15.03M 14.13M 13.04M 11.71M 9.97M 7.85M 6.31M 5.32M 4.78M 4.57M 4.55M 4.45M 4.31M 4.21M 3.36M 2.39M 1.76M 741.3K
Other Working Capital
-6.81M 1.12M 3.13M -1.2M 3.13M -354K -3.14M 392K -914.25K -1.45M 2.81M 1.58M 346.85K 1.34M -1.34M -1.74M -246K -50K
Other Non-Cash Items
-3.83M -6.8M -5.94M -4.69M -1.75M -83K 545K -187K -298K -247K 1.1M 2.06M 2.4M 2.51M 166.08M 166.01M 166.02M 166.13M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
-7.79M 4.58M 5.94M -1.06M 4.64M -420K -2.41M 742K -329K -846K 2.65M 2.39M 570K 456K -3.31M -4.55M -2.77M -914K
Operating Cash Flow
-115.4M -96.14M -81.21M -94.09M -80.38M -74.29M -68.44M -48.87M -44.86M -44.23M -43.53M -39.16M -36.66M -33.99M -30.15M -31.93M -34.15M -34.21M
Capital Expenditures
-610K -325K -325K -341K -325K -20K -25K -40K -94K -94K -89K -58K -2 n/a -21K -31K -31K -31.02K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a 135.15K 135.15K 135.15K 135.15K -6.47M -6.47M -6.47M n/a 75.55M 75.55M 75.55M
Purchase of Investments
-3.15B -3.95B -4.24B -4.2B -4.06B -2.88B -1.92B -1.39B -534.1M -410.29M -396.06M -295.56M -242.89M -159.7M -84.47M -26.47M -26.47M -26.47M
Sales Maturities Of Investments
3.24B 3.91B 4.05B 4.01B 3.86B 2.69B 2.06B 1.4B 538.03M 465.34M 229.03M 224.68M 169.99M 93.6M 59M -49.11M -47.11M -7.34M
Other Investing Acitivies
n/a n/a n/a n/a n/a -57.92K -57.92K -193.07K -191.06K -139.94K -167.04K 6.43M 6.43M 6.44M 12.93M 6.49M 6.49M 6.47M
Investing Cash Flow
89.05M -37.05M -191.86M -190.16M -196.35M -186.17M 135.05M 1.89M 3.84M 54.96M -167.13M -70.95M -72.9M -66.1M -12.55M 6.43M 8.44M 48.18M
Debt Repayment
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -24.44M -24.44M -24.44M -24.44M n/a n/a n/a
Other Financial Acitivies
152.47M 152.47M 157.11M 4.69M 4.63M 4.91M 310K 360K 394K 121K 84K 51K 23K 23K 23K 37K 31K 31K
Financial Cash Flow
15.3M 15.39M 157.2M 245.18M 229.99M 230.17M 88.4M 120.82M 145.03M 144.76M 144.72M 24.34M 23K 23K 104.28M 104.3M 113.23M 119.5M
Net Cash Flow
-11.06M -117.79M -115.87M -39.07M -46.75M -30.29M 155M 73.83M 104.01M 155.49M -65.94M -85.76M -109.53M -100.07M 61.58M 78.81M 87.52M 133.46M
Free Cash Flow
-116.01M -96.46M -81.54M -94.43M -80.71M -74.31M -68.47M -48.91M -44.96M -44.32M -43.62M -39.21M -36.66M -33.99M -30.17M -31.96M -34.18M -34.24M